HCID 86631064, compound → (Cis)-[4-chloro-2-[[2,3-dimethyl-4-(phenylacetyl)-1-piperazinyl]methyl]phenoxy]-acetic Acid

HRID 38282Notes

Reaction equation

HRID 38282 reaction equation
[Cl:1][C:2]1[CH:16]=[CH:15][C:5]([O:6][CH2:7][C:8]([O:10]C(C)(C)C)=[O:9])=[C:4]([CH2:17][N:18]2[CH2:23][CH2:22][N:21]([C:24](=[O:32])[CH2:25][C:26]3[CH:31]=[CH:30][CH:29]=[CH:28][CH:27]=3)[C@H:20]([CH3:33])[C@@H:19]2[CH3:34])[CH:3]=1>C(O)(C(F)(F)F)=O>[Cl:1][C:2]1[CH:16]=[CH:15][C:5]([O:6][CH2:7][C:8]([OH:10])=[O:9])=[C:4]([CH2:17][N:18]2[CH2:23][CH2:22][N:21]([C:24](=[O:32])[CH2:25][C:26]3[CH:31]=[CH:30][CH:29]=[CH:28][CH:27]=3)[C@H:20]([CH3:33])[C@@H:19]2[CH3:34])[CH:3]=1

Participants

3

Procedure

The product from example 71 part b) treated with TFA (10 ml) for 16 h. Concentration in vacuo and purification by RPHPLC gave the title product as a white foam (39 mg).

Workup

  1. concentrationConcentration
  2. customin vacuo and purification by RPHPLC

Sources & evidence

ORD record
ord-be08dd6f876d4af3aa0f440e528cfbe8
Source dataset
uspto-grants-2013_09
Patent number
US08524715B2

Reaction notes

Loading…